Novel synthesis naringenin-benzyl piperazine derivatives prevent glioblastoma invasion by inhibiting the hypoxia-induced IL6/JAK2/STAT3 axis and activating caspase-dependent apoptosis.

[1]  Zeng-hong Wu,et al.  Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma , 2022, BMC cancer.

[2]  Heung Kyu Lee,et al.  Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy , 2022, Cancers.

[3]  O. Doğanlar,et al.  Prolonged sub-lethal exposure to galaxolide (HHCB) and tonalide (AHTN) promotes the metastatic potential of glioblastoma tumor spheroids. , 2021, Neurotoxicology.

[4]  H. Daldrup-Link,et al.  Glioblastoma Multiforme (GBM): An overview of current therapies and mechanisms of resistance. , 2021, Pharmacological research.

[5]  A. Heimberger,et al.  The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma , 2021, Cancers.

[6]  Zhe-Shan Quan,et al.  Piperazine skeleton in the structural modification of natural products: a review , 2021, Journal of enzyme inhibition and medicinal chemistry.

[7]  Wajhul Qamar,et al.  Multi-Therapeutic Potential of Naringenin (4′,5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms , 2020, Plants.

[8]  O. Doğanlar,et al.  Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents. , 2020, Ecotoxicology and environmental safety.

[9]  J. Grandis,et al.  Targeting the JAK/STAT pathway in solid tumors , 2020, Journal of cancer metastasis and treatment.

[10]  Emre Delen,et al.  The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway , 2020, Journal of Korean Neurosurgical Society.

[11]  B. Kamińska,et al.  STAT Signaling in Glioma Cells. , 2020, Advances in experimental medicine and biology.

[12]  I. Kruk,et al.  Preparation and in vitro antioxidant activity of some novel flavone analogues bearing piperazine moiety. , 2019, Bioorganic chemistry.

[13]  K. Shokat,et al.  Cooperative blockade of PKCα and JAK2 drives apoptosis in glioblastoma. , 2019, Cancer research.

[14]  A. Alzahrani.  PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. , 2019, Seminars in cancer biology.

[15]  K. Skelding,et al.  Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets , 2019, Front. Oncol..

[16]  Han-Seung Shin,et al.  Sulfonylpiperazines based on a flavone as antioxidant and cytotoxic agents , 2019, Archiv der Pharmazie.

[17]  H. Badali,et al.  New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: Synthesis, in vitro evaluation and in silico study. , 2019, Bioorganic chemistry.

[18]  Shilong Zheng,et al.  Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models. , 2019, Bioorganic chemistry.

[19]  Emre Delen,et al.  Inhibition of the invasion of human glioblastoma U87 cell line by ruxolitinib: a molecular player of miR-17 and miR-20a regulating JAK/STAT pathway. , 2019, Turkish neurosurgery.

[20]  Jie Li,et al.  admetSAR 2.0: web‐service for prediction and optimization of chemical ADMET properties , 2018, Bioinform..

[21]  O. Doğanlar,et al.  Synthesis, Cancer‐Selective Antiproliferative and Apoptotic Effects of Some (±)‐Naringenin Cycloaminoethyl Derivatives , 2018, Chemistry & biodiversity.

[22]  A. Tiwari,et al.  Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents. , 2018, European journal of medicinal chemistry.

[23]  Ricardo J. Ferreira,et al.  Optimizing the flavanone core toward new selective nitrogen-containing modulators of ABC transporters. , 2018, Future medicinal chemistry.

[24]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[25]  Tinghan Li,et al.  Synthesis, evaluation and quantitative structure-activity relationship (QSAR) analysis of Wogonin derivatives as cytotoxic agents. , 2017, Bioorganic & medicinal chemistry letters.

[26]  R. Heim,et al.  Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis. , 2016, Angewandte Chemie.

[27]  J. Sung,et al.  Chrysin-piperazine conjugates as antioxidant and anticancer agents. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  Tong Li,et al.  A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway , 2016, Autophagy.

[29]  J. Heiss,et al.  B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients , 2016, Clinical Cancer Research.

[30]  Xiao Zhang,et al.  Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells. , 2016, Experimental and therapeutic medicine.

[31]  M. Akhter,et al.  Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents. , 2015, European journal of medicinal chemistry.

[32]  Xiuyu Wang,et al.  Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells , 2014, Journal of Neuro-Oncology.

[33]  R. Kunz,et al.  Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine series. , 2014, Journal of medicinal chemistry.

[34]  Yong-min Zhang,et al.  Synthesis and antitumor activity evaluation of chrysin derivatives. , 2014, European journal of medicinal chemistry.

[35]  Timothy L. Foley,et al.  4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide (ML267), a Potent Inhibitor of Bacterial Phosphopantetheinyl Transferase That Attenuates Secondary Metabolism and Thwarts Bacterial Growth , 2014, Journal of medicinal chemistry.

[36]  F. Ciregia,et al.  The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury. , 2013, Biochemical pharmacology.

[37]  B. Damania,et al.  AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV , 2013, Front. Immun..

[38]  B. Bao,et al.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. , 2012, Biochimica et biophysica acta.

[39]  Xiujie Wang,et al.  Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications. , 2012, Experimental cell research.

[40]  Jie Shen,et al.  admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..

[41]  M. Taha,et al.  Synthesis and biological activity assays of some new N1-(flavon-7-yl)amidrazone derivatives and related congeners. , 2012, European journal of medicinal chemistry.

[42]  N. Banik,et al.  Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. , 2012, Experimental cell research.

[43]  Wei-Chang Fu,et al.  Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[44]  J. Isaacs,et al.  A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion , 2011, PloS one.

[45]  Y. Tu,et al.  Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas , 2011, Medical oncology.

[46]  T. Tamiya,et al.  Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  Yong Yang,et al.  Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG(2) cells. , 2010, Cancer letters.

[48]  B. Bandgar,et al.  Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents. , 2010, Bioorganic & medicinal chemistry letters.

[49]  H. Lou,et al.  Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[50]  D. Sakthisekaran,et al.  Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. , 2008, Nutrition research.

[51]  D. Barreca,et al.  Flavonoid composition of Citrus juices. , 2007, Molecules.

[52]  A. Piersma,et al.  (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. , 2007, Toxicology and applied pharmacology.

[53]  P. Rasoanaivo,et al.  Synthesis and antimalarial evaluation of a series of piperazinyl flavones. , 2007, Bioorganic & medicinal chemistry letters.

[54]  U. Murthy,et al.  Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents. , 2006, Bioorganic & medicinal chemistry letters.

[55]  P. Lambin,et al.  The hypoxic proteome is influenced by gene-specific changes in mRNA translation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  M. Ishikawa,et al.  Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. , 2005, Biological & pharmaceutical bulletin.

[57]  Y. Patel,et al.  Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation , 2004, Breast Cancer Research and Treatment.

[58]  J. Marx.  How Cells Endure Low Oxygen , 2004, Science.

[59]  C. Gardana,et al.  Polyphenol Pattern and Antioxidant Activity of Different Tomato Lines and Cultivars , 2003, Annals of Nutrition and Metabolism.

[60]  P. Jones,et al.  Hypoxia and lung branching morphogenesis. , 2003, Advances in experimental medicine and biology.

[61]  Ferran Sánchez-Rabaneda,et al.  Liquid chromatographic/electrospray ionization tandem mass spectrometric study of the phenolic composition of cocoa (Theobroma cacao). , 2003, Journal of mass spectrometry : JMS.

[62]  L. Poellinger,et al.  Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Ho,et al.  Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. , 2000, Pharmaceutica acta Helvetiae.

[64]  T. Nagem,et al.  Hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations. , 1999, Pharmacological research.

[65]  M. Nair,et al.  Antioxidant polyphenols from tart cherries (Prunus cerasus). , 1999, Journal of agricultural and food chemistry.

[66]  G. Lewin,et al.  Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships. , 1999, Journal of medicinal chemistry.

[67]  N Guthrie,et al.  Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. , 1996, Nutrition and cancer.

[68]  R. K. Bhattacharya,et al.  Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine. , 1989, Carcinogenesis.